JP2016504315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504315A5 JP2016504315A5 JP2015547441A JP2015547441A JP2016504315A5 JP 2016504315 A5 JP2016504315 A5 JP 2016504315A5 JP 2015547441 A JP2015547441 A JP 2015547441A JP 2015547441 A JP2015547441 A JP 2015547441A JP 2016504315 A5 JP2016504315 A5 JP 2016504315A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- immunogenic composition
- combination
- virus
- trivalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737679P | 2012-12-14 | 2012-12-14 | |
| US61/737,679 | 2012-12-14 | ||
| PCT/US2013/073757 WO2014093182A1 (en) | 2012-12-14 | 2013-12-07 | Compositions, methods of administration and uses for trivalent dengue virus formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016504315A JP2016504315A (ja) | 2016-02-12 |
| JP2016504315A5 true JP2016504315A5 (enExample) | 2017-01-26 |
Family
ID=50934851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015547441A Pending JP2016504315A (ja) | 2012-12-14 | 2013-12-07 | 三価デングウイルス製剤に関する組成物、投与方法および使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9878031B2 (enExample) |
| EP (1) | EP2931310A4 (enExample) |
| JP (1) | JP2016504315A (enExample) |
| CA (1) | CA2933472A1 (enExample) |
| WO (1) | WO2014093182A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3177572C (en) | 2013-03-15 | 2026-02-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for dengue virus chimeric constructs in vaccines |
| WO2016130786A2 (en) * | 2015-02-15 | 2016-08-18 | Integral Molecular, Inc. | Flaviviridae proteins and virions and methods of use thereof |
| EP3442571A1 (en) | 2016-04-13 | 2019-02-20 | Takeda Vaccines, Inc. | Compositions and methods of vaccination against dengue virus in children and young adults |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| CN112912106A (zh) * | 2018-09-05 | 2021-06-04 | 武田疫苗股份有限公司 | 登革热疫苗单位剂量及其施用 |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| MX2022001742A (es) * | 2019-08-16 | 2022-04-07 | Takeda Vaccines Inc | Metodos para prevenir el dengue y la hepatitis a. |
| CN120225693A (zh) * | 2022-11-18 | 2025-06-27 | 武田疫苗股份有限公司 | 测定制剂中具有包含至少一个减毒基因座的核苷酸序列的活减毒黄病毒的比例的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2941182A1 (en) | 2000-02-16 | 2001-08-23 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Avirulent, immunogenic flavivirus chimeras |
| US20040120964A1 (en) | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| AU2003239932A1 (en) | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| WO2006044857A2 (en) | 2004-10-20 | 2006-04-27 | Acambis Inc. | Vaccines against japanese encephalitis virus and west nile virus |
| WO2006134433A1 (en) * | 2005-06-17 | 2006-12-21 | Sanofi Pasteur | Dengue serotype 1 attenuated strain |
| BRPI0613287A2 (pt) | 2005-06-17 | 2010-12-28 | Sanofi Pasteur | cepa do vìrus da dengue-2 vivo atenuada, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada codificadas pela seq id n .1 ou fragmentos desta e fragmento da poliproteìna |
| EP1924280A4 (en) | 2005-08-10 | 2008-12-10 | Acambis Inc | VACCINATION AGAINST DENGUE VIRUS INFECTION |
| DK2589602T3 (en) | 2006-08-15 | 2016-07-25 | The Government Of The U S A As Repr By The Secretary Dept Of Health & Human Services The Nat Inst Of | Development of dengue virus vaccine components |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| WO2008157136A1 (en) | 2007-06-14 | 2008-12-24 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Chimeric sle/dengue type 4 antigenic viruses |
| WO2010085358A2 (en) | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| US9211323B2 (en) * | 2009-06-01 | 2015-12-15 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| US20120294889A1 (en) | 2010-11-12 | 2012-11-22 | Paxvax, Inc. | Chimeric Flavivirus Vaccines |
| EP2858668A1 (en) | 2012-06-10 | 2015-04-15 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
-
2013
- 2013-12-07 JP JP2015547441A patent/JP2016504315A/ja active Pending
- 2013-12-07 WO PCT/US2013/073757 patent/WO2014093182A1/en not_active Ceased
- 2013-12-07 EP EP13863155.1A patent/EP2931310A4/en not_active Withdrawn
- 2013-12-07 US US14/652,066 patent/US9878031B2/en not_active Expired - Fee Related
- 2013-12-07 CA CA2933472A patent/CA2933472A1/en not_active Abandoned
-
2017
- 2017-12-15 US US15/844,030 patent/US20180228887A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013542224A5 (enExample) | ||
| JP2019151636A5 (enExample) | ||
| ATE526411T1 (de) | Avirulente, immunogene flavivirus-chimäre | |
| JP2015535302A (ja) | ビリオン分解に影響を及ぼすフラビウイルスのエンベロープタンパク質変異 | |
| KR20130138789A (ko) | 재조합 서브유닛 뎅기 바이러스 백신 | |
| AU2017250696A1 (en) | Compositions and methods of vaccination against dengue virus in children and young adults | |
| JP2010505801A5 (enExample) | ||
| JP2015524421A5 (enExample) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2017526689A5 (enExample) | ||
| EP3474891B1 (en) | Vaccine compositions comprising an attenuated mutant zika virus | |
| WO2017156511A8 (en) | Live attenuated zika virus vaccine | |
| US9861692B2 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| KR20170075775A (ko) | 백신 및 진단제 개발을 위한 재조합 뎅기 바이러스에 대한 방법 및 조성물 | |
| EP3236997B1 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| Zheng et al. | Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection | |
| EP3481848B1 (en) | Genomic sequences encoding for an attenuated mutant zika virus | |
| JP5657204B2 (ja) | デングウイルスのカプシドタンパク質を有する、デングウイルスに対する防御反応を誘導することができる医薬品組成物 | |
| CN103352047B (zh) | 旋毛虫肌幼虫es抗原基因疫苗及其制备方法 | |
| Vartian et al. | Immunogenicity and safety of FSME-IMMUN 0.5 ml using a rapid immunization schedule | |
| Li et al. | Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice | |
| López et al. | New evidence on the virus capsid as a vaccine candidate against the Dengue 2 virus without the induction of the neutralizing antibodies | |
| Caine | Understanding host adaptation and disease progression of enterovirus 71 using mouse models, reverse genetics, and in vivo imaging | |
| Liu | Immunization of West Nile recombinant envelope Domain III with equine CD40 ligand protein vaccine induced specific immune response in rabbits and horses | |
| TH96612A (th) | วิธีการให้ภูมิคุ้มกันต่อ 4 ซีไรไทป์ของไข้เดงกี |